/LNDZF
LNDZF Stock - Evome Medical Technologies Inc.
Healthcare|Medical - DevicesOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
40
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.25
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for LNDZF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.38
52W High$0.10
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $62.63M | $18.31M | $-33,547 | $352,130 | $3.15M |
| Gross Profit | $22.53M | $5.96M | $-12,383,749 | $-20,328 | $3.09M |
| Gross Margin | 36.0% | 32.6% | 36914.6% | -5.8% | 98.0% |
| Operating Income | $-5,521,949 | $-4,838,745 | $-1,023,831 | $-1,688,623 | $-760,569 |
| Net Income | $-15,602,915 | $-4,372,019 | $-2,667,423 | $-2,341,345 | $-760,569 |
| Net Margin | -24.9% | -23.9% | 7951.3% | -664.9% | -24.2% |
| EPS | $-0.16 | $-0.10 | $-0.06 | $-0.07 | $-0.02 |
Company Overview
Evome Medical Technologies Inc. develops, manufactures, and distributes medical devices and products in the Americas and internationally. The company's product portfolio includes various devices for pain management and physical therapy treatments, such as isokinetic dynamometers, perturbation gait trainers, balance assessment and recovery devices, neuromuscular electrical and transcutaneous electrical nerve stimulation devices, ultrasound treatment devices, wearable technology, and other products designed for the prevention, treatment, and rehabilitation of the human body.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
LNDZFBeat Rate
50%
Last 2 quarters
Avg Surprise
-10.0%
EPS vs Estimate
Beats / Misses
1/1
Last 12 quarters
Latest EPS
$-0.01
Q4 2024
EPS Surprise History
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Dec 22, 2025 | — | — | — | — |
Q4 2025 | Dec 18, 2025 | — | — | — | — |
Q3 2025 | Aug 28, 2025 | — | — | — | — |
Q2 2025 | May 29, 2025 | — | — | — | — |
Q1 2025 | Mar 28, 2025 | — | — | — | — |
Q4 2024 | Nov 18, 2024 | — | $-0.01 | — | — |
Q3 2024 | Aug 12, 2024 | — | $-0.02 | — | — |
Q2 2024 | May 30, 2024 | — | — | — | — |
Q2 2024 | Apr 16, 2024 | — | $-0.21 | — | — |
Q4 2023 | Nov 15, 2023 | — | $0.02 | — | — |
Q3 2023 | Aug 15, 2023 | — | $-0.01 | — | — |
Q2 2023 | May 16, 2023 | — | $-0.02 | — | — |
Q1 2023 | Jan 17, 2023 | — | $-0.02 | — | — |
Q4 2022 | Oct 17, 2022 | — | $-0.13 | — | — |
Q3 2022 | Jul 13, 2022 | $-0.05 | $-0.05 | +2.0% | ✓ BEAT |
Q2 2022 | Jun 1, 2022 | — | $-0.02 | — | — |
Q1 2022 | Jan 14, 2022 | — | $-0.03 | — | — |
Q4 2021 | Oct 19, 2021 | $-0.02 | $-0.02 | -22.0% | ✗ MISS |
Q3 2021 | Jul 14, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 25, 2021 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about LNDZF
What is LNDZF's current stock price?
Evome Medical Technologies Inc. (LNDZF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for LNDZF?
No analyst price targets are currently available for this stock.
What sector is Evome Medical Technologies Inc. in?
Evome Medical Technologies Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is LNDZF's market cap?
Evome Medical Technologies Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does LNDZF pay dividends?
No, Evome Medical Technologies Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACHKF
Achiko AG
$0.00
Mkt Cap: $0.0B
ALSE
Alseres Pharmaceuticals, Inc.
$0.01
Mkt Cap: $0.0B
AQQRF
Aquarius Surgical Technologies Inc.
$0.00
Mkt Cap: $0.0B
FLURF
FluroTech Ltd.
$0.00
Mkt Cap: $0.0B
NHIQ
NantHealth, Inc.
$0.01
Mkt Cap: $0.0B
NXNN
Nexeon MedSystems Inc.
$0.00
Mkt Cap: $0.0B
OSA
ProSomnus, Inc.
$0.47
Mkt Cap: $0.0B
PLSI
Phoenix Life Sciences International Limited
$0.00
Mkt Cap: $0.0B
SNDD
RedHawk Holdings Corp.
$0.00
Mkt Cap: $0.0B
VEGGD
Better Plant Sciences Inc.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to LNDZF for comparison